These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 10203370

  • 1. Cytokine removal during continuous hemofiltration in septic patients.
    De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH.
    J Am Soc Nephrol; 1999 Apr; 10(4):846-53. PubMed ID: 10203370
    [Abstract] [Full Text] [Related]

  • 2. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
    Heering P, Morgera S, Schmitz FJ, Schmitz G, Willers R, Schultheiss HP, Strauer BE, Grabensee B.
    Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
    [Abstract] [Full Text] [Related]

  • 3. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C, Chauveau P, Guisset O, Cazin MC, Lasseur C, Gabinsky C, Winnock S, Montaudon D, Bedry R, Nouts C, Pillet O, Benissan GG, Favarel-Guarrigues JC, Castaing Y.
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [Abstract] [Full Text] [Related]

  • 4. Myoglobin clearance and removal during continuous venovenous hemofiltration.
    Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J.
    Intensive Care Med; 1999 Oct; 25(10):1169-72. PubMed ID: 10551978
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.
    Kade G, Lubas A, Rzeszotarska A, Korsak J, Niemczyk S.
    Med Sci Monit; 2016 Nov 13; 22():4338-4344. PubMed ID: 27840404
    [Abstract] [Full Text] [Related]

  • 6. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report.
    Bruenger F, Kizner L, Weile J, Morshuis M, Gummert JF.
    Int J Artif Organs; 2015 Feb 13; 38(2):113-6. PubMed ID: 25656010
    [Abstract] [Full Text] [Related]

  • 7. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.
    Rogiers P, Zhang H, Pauwels D, Vincent JL.
    Crit Care Med; 2003 Apr 13; 31(4):1219-25. PubMed ID: 12682496
    [Abstract] [Full Text] [Related]

  • 8. A pilot study of high-adsorption hemofiltration in human septic shock.
    Haase M, Silvester W, Uchino S, Goldsmith D, Davenport P, Tipping P, Boyce N, Bellomo R.
    Int J Artif Organs; 2007 Feb 13; 30(2):108-17. PubMed ID: 17377905
    [Abstract] [Full Text] [Related]

  • 9. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.
    Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Béraud JJ.
    J Nephrol; 2002 Feb 13; 15(2):150-7. PubMed ID: 12018631
    [Abstract] [Full Text] [Related]

  • 10. Blood and plasma treatments: the rationale of high-volume hemofiltration.
    Honoré PM, Joannes-Boyau O, Gressens B.
    Contrib Nephrol; 2007 Feb 13; 156():387-95. PubMed ID: 17464149
    [Abstract] [Full Text] [Related]

  • 11. [Effects of high volume hemofiltration on hemodynamics and oxygen metabolism at early stage of septic shock in piglet models].
    Chen WM, Lu GP, Lu ZJ, Zhang LE.
    Zhonghua Er Ke Za Zhi; 2013 Nov 13; 51(11):819-24. PubMed ID: 24484555
    [Abstract] [Full Text] [Related]

  • 12. Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status.
    Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Müller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH.
    Am J Kidney Dis; 2004 Mar 13; 43(3):444-53. PubMed ID: 14981602
    [Abstract] [Full Text] [Related]

  • 13. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS, Matzke GR, Frye RF, Palevsky PM.
    Am J Kidney Dis; 1998 Jun 13; 31(6):1019-27. PubMed ID: 9631848
    [Abstract] [Full Text] [Related]

  • 14. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W.
    Ren Fail; 1997 May 13; 19(3):443-54. PubMed ID: 9154661
    [Abstract] [Full Text] [Related]

  • 15. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.
    Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR.
    Crit Care Med; 1998 Dec 13; 26(12):1995-2000. PubMed ID: 9875910
    [Abstract] [Full Text] [Related]

  • 16. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients.
    Dahaba AA, Elawady GA, Rehak PH, List WF.
    Anaesth Intensive Care; 2002 Jun 13; 30(3):269-74. PubMed ID: 12075632
    [Abstract] [Full Text] [Related]

  • 17. High-volume haemofiltration in human septic shock.
    Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P.
    Intensive Care Med; 2001 Jun 13; 27(6):978-86. PubMed ID: 11497156
    [Abstract] [Full Text] [Related]

  • 18. High cut-off hemofiltration versus standard hemofiltration: effect on plasma cytokines.
    Atan R, Peck L, Visvanathan K, Skinner N, Eastwood G, Bellomo R, Storr M, Goehl H.
    Int J Artif Organs; 2016 Nov 11; 39(9):479-486. PubMed ID: 27834446
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High volume continuous venovenous haemofiltration (HV-CVVH) in an equine endotoxaemic shock model.
    Veenman JN, Dujardint CL, Hoek A, Grootendorst A, Klein WR, Rutten VP.
    Equine Vet J; 2002 Jul 11; 34(5):516-22. PubMed ID: 12358057
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.